skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Triazolopyrimidine and triazolopyridine scaffolds as TDP2 inhibitors

Journal Article · · Bioorganic and Medicinal Chemistry Letters

Tyrosyl-DNA phosphodiesterase 2 (TDP2) repairs topoisomerase II (TOP2) mediated DNA damages and causes cellular resistance to clinically used TOP2 poisons. Inhibiting TDP2 can potentially sensitize cancer cells toward TOP2 poisons. Commercial compound P10A10, to which the structure was assigned as 7-phenyl triazolopyrimidine analogue 6a, was previously identified as a TDP2 inhibitor hit in our virtual and fluorescence-based biochemical screening campaign. In this artilce, we report that the hit validation through resynthesis and structure elucidation revealed the correct structure of P10A10 (Chembridge ID 7236827) to be the 5-phenyl triazolopyrimidine regioisomer 7a. Subsequent structure–activity relationship (SAR) via the synthesis of a total of 47 analogues of both the 5-phenyl triazolopyrimidine scaffold (7) and its bioisosteric triazolopyridine scaffold (17) identified four derivatives (7a, 17a, 17e, and 17z) with significant TDP2 inhibition (IC50 < 50 μM), with 17z showing excellent cell permeability and no cytotoxicity.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
Academic Health Center Faculty Research Development Grant Program; National Institutes of Health (NIH); National Science Foundation (NSF)
Grant/Contract Number:
GM118047; 1224900
OSTI ID:
1502193
Journal Information:
Bioorganic and Medicinal Chemistry Letters, Vol. 29, Issue 2; ISSN 0960-894X
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 15 works
Citation information provided by
Web of Science

References (48)

Roles of eukaryotic topoisomerases in transcription, replication and genomic stability journal September 2016
Drugging Topoisomerases: Lessons and Challenges journal January 2013
End-processing nucleases and phosphodiesterases: An elite supporting cast for the non-homologous end joining pathway of DNA double-strand break repair journal July 2016
Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2) journal July 2014
Mutant p53 cooperates with ETS2 to promote etoposide resistance journal April 2012
TDP2/TTRAP Is the Major 5′-Tyrosyl DNA Phosphodiesterase Activity in Vertebrate Cells and Is Critical for Cellular Resistance to Topoisomerase II-induced DNA Damage* journal January 2011
A human 5′-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage journal October 2009
Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential journal November 2016
An RNA virus hijacks an incognito function of a DNA repair enzyme journal August 2012
Divergent Requirement for a DNA Repair Enzyme during Enterovirus Infections journal March 2016
VPg unlinkase/TDP2 in cardiovirus infected cells: Re-localization and proteolytic cleavage journal March 2018
Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses journal September 2014
New fluorescence-based high-throughput screening assay for small molecule inhibitors of tyrosyl-DNA phosphodiesterase 2 (TDP2) journal June 2018
Generation of assays and antibodies to facilitate the study of human 5′-tyrosyl DNA phosphodiesterase journal May 2013
Discovery of selective inhibitors of tyrosyl-DNA phosphodiesterase 2 by targeting the enzyme DNA-binding cleft journal July 2016
Synthesis and biological evaluation of new fluorinated and chlorinated indenoisoquinoline topoisomerase I poisons journal April 2016
Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl–DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl–DNA Phosphodiesterase 2 (Tdp2) journal April 2017
Toxoflavins and Deazaflavins as the First Reported Selective Small Molecule Inhibitors of Tyrosyl-DNA Phosphodiesterase II journal July 2013
Deazaflavin Inhibitors of Tyrosyl-DNA Phosphodiesterase 2 (TDP2) Specific for the Human Enzyme and Active against Cellular TDP2 journal May 2016
Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2 journal June 2016
Isoquinoline-1,3-diones as Selective Inhibitors of Tyrosyl DNA Phosphodiesterase II (TDP2) journal March 2016
Depletion of tyrosyl DNA phosphodiesterase 2 activity enhances etoposide-mediated double-strand break formation and cell killing journal July 2016
Synthesis and screening of triazolopyrimidine scaffold as multi-functional agents for Alzheimer's disease therapies journal August 2016
Characterization of Brain-Penetrant Pyrimidine-Containing Molecules with Differential Microtubule-Stabilizing Activities Developed as Potential Therapeutic Agents for Alzheimers Disease and Related Tauopathies journal March 2016
Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase journal September 2016
Synthesis and Evaluation of 1,2,4-Triazolo[1,5- a ]pyrimidines as Antibacterial Agents Against Enterococcus faecium journal May 2015
Design, synthesis and biological evaluation of [1,2,4]triazolo[1,5-a]pyrimidines as potent lysine specific demethylase 1 (LSD1/KDM1A) inhibitors journal January 2017
Synthesis of monomeric and dimeric steroids containing [1,2,4]triazolo[1,5-a]pyrimidines journal December 2016
Novel Selective Inhibitor of Leishmania (Leishmania) amazonensis Arginase journal May 2015
A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria journal October 2016
Tetrahydro-2-naphthyl and 2-Indanyl Triazolopyrimidines Targeting Plasmodium falciparum Dihydroorotate Dehydrogenase Display Potent and Selective Antimalarial Activity journal May 2016
A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein–Basic Protein 1 (PA-PB1) Subunits journal April 2015
Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: Optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches journal March 2015
Synthesis and structure activity relationship investigation of triazolo[1,5-a]pyrimidines as CB2 cannabinoid receptor inverse agonists journal May 2016
Design and Synthesis of Novel and Selective Phosphodiesterase 2 (PDE2a) Inhibitors for the Treatment of Memory Disorders journal February 2017
Synthesis of [1,2,4]triazolo[1,5-a]pyrimidine (microreview) journal March 2016
The Structure of Certain Polyazaindenes. IV. Compounds from β-Keto Acetals and β-Methoxyvinyl Ketones 1 journal June 1959
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivatives journal January 2017
Triazolopyridines as Selective JAK1 Inhibitors: From Hit Identification to GLPG0634 journal October 2014
Bioactivation and Hepatotoxicity of Nitroaromatic Drugs journal October 2006
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design journal April 2011
N-Arylsulfonyl-α-amino carboxamides are potent and selective inhibitors of the chemokine receptor CCR10 that show efficacy in the murine DNFB model of contact hypersensitivity journal November 2016
Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism Diuretics journal April 2012
Inhibitory effects of a series of 7-substituted-indazoles toward nitric oxide synthases: Particular potency of 1H-indazole-7-carbonitrile journal June 2008
Pyridine isosteres of the .beta.-adrenergic antagonists, 2-(p-nitrophenyl)-1-isopropylamino-2-ethanol and 3-(p-nitrophenoxy)-1-isopropylamino-2-propanol journal December 1972
Spectral and Crystallographic Study of Pyridinic Analogues of Nimesulide: Determination of the Active Form of Methanesulfonamides as COX-2 Selective Inhibitors journal November 2002
Development of Novel Alkene Oxindole Derivatives As Orally Efficacious AMP-Activated Protein Kinase Activators journal March 2013
Design and Synthesis of Novel α 1 a Adrenoceptor-Selective Antagonists. 1. Structure−Activity Relationship in Dihydropyrimidinones journal November 1999